United Nations Security Council Resolution 362
United Nations Security Council Resolution 362 was adopted on 23 October 1974. The resolution addressed the ongoing Middle East conflict and the role of the United Nations Emergency Force (UNEF) in maintaining peace and security in the region.
Background[edit | edit source]
The Middle East conflict, particularly the Arab-Israeli conflict, has been a significant focus of the United Nations Security Council (UNSC) since the establishment of the State of Israel in 1948. The UNEF was initially deployed in 1956 following the Suez Crisis to supervise the cessation of hostilities and ensure the withdrawal of invading forces.
Provisions of the Resolution[edit | edit source]
Resolution 362 reaffirmed the need for the continued presence of the UNEF in the region to monitor the ceasefire and prevent further hostilities. The resolution called for:
- The extension of the mandate of the UNEF for an additional six months.
- The Secretary-General to report on the implementation of the resolution and the situation in the region.
- All parties involved to cooperate fully with the UNEF to ensure the maintenance of peace and security.
Voting[edit | edit source]
The resolution was adopted unanimously by the members of the United Nations Security Council.
Impact[edit | edit source]
The adoption of Resolution 362 underscored the international community's commitment to peacekeeping efforts in the Middle East. The continued presence of the UNEF played a crucial role in stabilizing the region and preventing the escalation of conflict.
See also[edit | edit source]
- United Nations Security Council Resolutions 301 to 400
- United Nations Emergency Force
- Arab-Israeli conflict
- Middle East
References[edit | edit source]
External links[edit | edit source]
- [Link to the full text of the resolution]
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.Contributors: Prab R. Tumpati, MD